XKRX
192820
Market cap1.32bUSD
Apr 11, Last price
165,000.00KRW
1D
3.00%
1Q
11.94%
Jan 2017
38.08%
IPO
113.73%
Name
Cosmax Inc
Chart & Performance
Profile
Cosmax, Inc. researches, develops, produces, and sells cosmetic, health function food, and pharmaceutical products in Korea and internationally. The company offers skincare, color cosmetics, and hair care products, as well as mask sheets and eye patches. It also develops and manufactures medical supplies and devices; raw materials for cosmetic products; and functional containers and filling packaging products for cosmetics. The company was formerly known as Miroto Korea and changed its name to Cosmax, Inc. in 1994. Cosmax, Inc. was founded in 1992 and is headquartered in Hwaseong, South Korea.
Valuation
Title KRW in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|---|
2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | |
Income | ||||||||||
Revenues | 2,166,089,637 21.86% | 1,777,494,448 11.08% | 1,600,125,770 0.54% | |||||||
Cost of revenue | 1,862,877,501 | 1,565,471,444 | 1,538,154,270 | |||||||
Unusual Expense (Income) | ||||||||||
NOPBT | 303,212,136 | 212,023,004 | 61,971,500 | |||||||
NOPBT Margin | 14.00% | 11.93% | 3.87% | |||||||
Operating Taxes | 49,213,493 | 46,420,850 | 22,616,508 | |||||||
Tax Rate | 16.23% | 21.89% | 36.50% | |||||||
NOPAT | 253,998,643 | 165,602,154 | 39,354,993 | |||||||
Net income | 85,796,824 50.16% | 57,137,183 -447.41% | (16,446,827) -147.90% | |||||||
Dividends | (5,672,831) | (6,264,361) | ||||||||
Dividend yield | 0.34% | 0.75% | ||||||||
Proceeds from repurchase of equity | (114,800,866) | 3,058 | ||||||||
BB yield | 8.01% | 0.00% | ||||||||
Debt | ||||||||||
Debt current | 526,328,955 | 453,747,974 | 516,985,096 | |||||||
Long-term debt | 274,840,565 | 196,975,656 | 137,670,156 | |||||||
Deferred revenue | ||||||||||
Other long-term liabilities | 85,873,850 | 181,413,405 | 49,347,216 | |||||||
Net debt | 515,614,184 | 275,456,633 | 430,466,801 | |||||||
Cash flow | ||||||||||
Cash from operating activities | 72,966,186 | 231,020,762 | 102,531,468 | |||||||
CAPEX | (164,916,321) | (86,283,324) | (84,364,779) | |||||||
Cash from investing activities | (160,026,022) | (104,497,982) | (31,251,949) | |||||||
Cash from financing activities | 67,515,595 | (39,233,386) | 3,471,944 | |||||||
FCF | 46,320,157 | 227,872,040 | 27,886,096 | |||||||
Balance | ||||||||||
Cash | 288,648,889 | 286,391,879 | 181,374,448 | |||||||
Long term investments | (3,093,553) | 88,875,118 | 42,814,003 | |||||||
Excess cash | 177,250,854 | 286,392,275 | 144,182,162 | |||||||
Stockholders' equity | 424,662,792 | 301,574,657 | 186,362,624 | |||||||
Invested Capital | 1,131,161,113 | 850,618,756 | 941,747,060 | |||||||
ROIC | 25.63% | 18.48% | 4.10% | |||||||
ROCE | 22.53% | 18.65% | 5.71% | |||||||
EV | ||||||||||
Common stock shares outstanding | 11,344 | 11,346 | 11,346 | |||||||
Price | 149,100.00 17.96% | 126,400.00 70.58% | 74,100.00 -15.22% | |||||||
Market cap | 1,691,442,585 17.95% | 1,434,091,677 70.58% | 840,713,554 -10.26% | |||||||
EV | 2,242,469,324 | 1,705,592,803 | 1,134,301,620 | |||||||
EBITDA | 372,019,194 | 271,456,655 | 120,780,097 | |||||||
EV/EBITDA | 6.03 | 6.28 | 9.39 | |||||||
Interest | 45,349,292 | 32,114,913 | 20,969,716 | |||||||
Interest/NOPBT | 14.96% | 15.15% | 33.84% |